About Biosensors

Biosensors International Group, Ltd. develops, manufactures and commercializes innovative medical devices used in interventional cardiology and critical care procedures.

We are well positioned to emerge as a leader in drug-eluting stents ("DES"), an evolving therapy that is rapidly gaining market share from traditional cardiovascular therapies.

In June 2006, Biosensors was named one of 50 medical technology companies to be watched in Medical Device and Diagnostic Industry magazine's 50 companies to watch, which cited Biosensors' innovative biodegradable-polymer DES as one of the reasons for the Company to be watched.

Recent News Releases

Video Recording of company update and results briefing of Financial Year Ended 31 March 2008


Click here to view
Click here to download presentation slides